HCA Healthcare Inc. ($HCA) Stock Forecast: Down 5.2% Today

What is HCA Healthcare Inc.?

HCA Healthcare, Inc. ($HCA) is a leading healthcare services provider with a focus on strategic investments in digital technologies and operational scale. The company has been demonstrating resilience and growth in the evolving healthcare landscape.

Why is HCA Healthcare Inc. going down?

HCA stock is down 5.2% on Mar 17, 2026 16:45

• An increase in holdings by Mercer Global Advisors Inc. ADV in HCA Healthcare could reflect confidence in the company's future prospects, although market sentiment may have been influenced by various factors.
• Despite HCA Healthcare's strong performance and strategic investments, notable insider selling activities in the healthcare sector, involving CEOs and Directors of companies like ResMed Inc. and Tenet Healthcare Corporation, might have had a negative impact on investor sentiment.
• Analysts supporting a "Moderate Buy" rating for HCA Healthcare amidst insider selling and institutional adjustments present a mixed outlook, potentially contributing to the stock's bearish movement.
• HCA Healthcare's emphasis on AI-driven efficiencies and disciplined capital deployment for future growth, highlighted in industry conferences, contrasts with insider selling trends in the sector, complicating market dynamics and potentially affecting the stock price adversely.

HCA Price Chart

HCA Technical Analysis

HCA News

Mercer Global Advisors Inc. ADV Buys 7,588 Shares of HCA Healthcare, Inc. $HCA

Mercer Global Advisors Inc. ADV increased its holdings in HCA Healthcare, Inc. by 5.3%, acquiring an additional 7,588 shares in the third quarter to own a total of 149,727 shares valued at $63.81 million. Other institutional investors also adjusted their positions in HCA Healthcare, which last reported strong earnings, beating analyst estimates, and increased its quarterly dividend to $0.78 per share. Despite some insider selling, analysts generally maintain a "Moderate Buy" rating for the stock, with an average target price of $537.73.

https://www.marketbeat.com/instant-alerts/filing-mercer-global-advisors-inc-adv-buys-7588-shares-of-hca-healthcare-inc-hca-2026-03-17/

California Public Employees Retirement System Has $78.58 Million Position in ResMed Inc. $RMD

The California Public Employees Retirement System increased its stake in ResMed Inc. (NYSE:RMD) by 5.8% in the third quarter, holding 287,061 shares valued at approximately $78.58 million. This comes as insider selling by CEO Michael J. Farrell and Director Peter C. Farrell continued, totaling over $1.7 million in sales. ResMed reported strong Q1 results, beating EPS and revenue estimates, and announced a quarterly dividend of $0.60 per share.

https://www.marketbeat.com/instant-alerts/filing-california-public-employees-retirement-system-has-7858-million-position-in-resmed-inc-rmd-2026-03-17/

Ameriprise Financial Inc. Sells 283,312 Shares of Tenet Healthcare Corporation $THC

Ameriprise Financial Inc. reduced its stake in Tenet Healthcare Corporation by 13.4% in the third quarter, selling 283,312 shares and now owning 1,836,111 shares valued at $372.8 million. Other institutional investors have also adjusted their holdings, while analysts maintain a "Moderate Buy" consensus rating with an average price target of $250.56. Tenet Healthcare recently reported strong earnings, exceeding analyst expectations, and has seen significant insider selling activity.

https://www.marketbeat.com/instant-alerts/filing-ameriprise-financial-inc-sells-283312-shares-of-tenet-healthcare-corporation-thc-2026-03-17/

HCA: Strategic investments and operational scale drive growth and resilience amid evolving payer dynamics

HCA Healthcare (HCA) is positioned for continued growth in 2026, building on solid 2025 results, through strategic investments in digital, AI, and network expansion. The company demonstrates resilience with a disciplined capital deployment strategy, navigating shifts in payer mix and manageable Medicaid changes. Operational efficiency is further enhanced by leveraging AI and its scale, as discussed at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference.

https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3094891:0-hca-strategic-investments-and-operational-scale-drive-growth-and-resilience-amid-evolving-payer-dynamics/

HCA: Strong growth, disciplined capital deployment, and AI-driven efficiencies shape 2026 outlook

HCA Healthcare's 2026 outlook is shaped by strong growth, disciplined capital deployment, and AI-driven efficiencies. The company achieved solid performance in 2025 with 2.4% admission growth and margin expansion, driven by network development and digital investments. Key themes for 2026 include exchange and Medicaid dynamics, regulatory changes, and cost management.

https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3094783:0-hca-strong-growth-disciplined-capital-deployment-and-ai-driven-efficiencies-shape-2026-outlook/

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.3% Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

05.00.2026 - HCA Stock was up 1.7%

• HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
• The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
• The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
• Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

17.02.2026 - HCA Stock was down 5.2%

• An increase in holdings by Mercer Global Advisors Inc. ADV in HCA Healthcare could reflect confidence in the company's future prospects, although market sentiment may have been influenced by various factors.
• Despite HCA Healthcare's strong performance and strategic investments, notable insider selling activities in the healthcare sector, involving CEOs and Directors of companies like ResMed Inc. and Tenet Healthcare Corporation, might have had a negative impact on investor sentiment.
• Analysts supporting a "Moderate Buy" rating for HCA Healthcare amidst insider selling and institutional adjustments present a mixed outlook, potentially contributing to the stock's bearish movement.
• HCA Healthcare's emphasis on AI-driven efficiencies and disciplined capital deployment for future growth, highlighted in industry conferences, contrasts with insider selling trends in the sector, complicating market dynamics and potentially affecting the stock price adversely.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

22.06.2025 - HCA Stock was down 0.6%

• The bearish movement in HCA stock today could be attributed to the lack of optimistic expectations for its upcoming Q2 earnings:
• Analysts are cautious about the potential for an earnings beat, as the company may not possess the right combination of key ingredients.
• Investors might be adjusting their positions in anticipation of underwhelming performance in key metrics for the quarter ended June 2025.
• The market sentiment seems to be influenced by the uncertainty surrounding HCA Healthcare's earnings growth prospects, leading to a downward pressure on the stock price.

12.02.2026 - HCA Stock was up 2.7%

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.

24.09.2025 - HCA Stock was up 2.4%

• HCA Healthcare (HCA) exceeded expectations in Q3 earnings and revenues, reflecting a strong performance during the last quarter.
• Analysts adjusted their forecasts for HCA Healthcare before the earnings announcement, expecting a rise in quarterly earnings per share.
• With a track record of outperforming the market over the past decade, HCA Healthcare has consistently delivered returns to its investors.
• Despite concerns about rising costs affecting Q3 earnings, the company's robust revenue growth has fueled a bullish trend in its stock.

24.10.2025 - HCA Stock was down 1.9%

• The bearish movement in HCA stock today could be due to concerns about increased competition and potential market share loss following Teladoc's aggressive acquisition strategy in the healthcare industry.
• Investors might be worried that Teladoc's expanding global footprint and growth across key segments could pose a threat to HCA's market position and profitability.
• The market might be reacting to the perceived long-term impact of Teladoc's strategic moves on HCA's business prospects, leading to a sell-off of HCA shares in today's trading session.